MobiHealth News May 27, 2025
Marcel Botha, cofounder and CEO of 10XBeta, warns that President Trump’s tariffs may jeopardize the quality and safety of medical innovations and hinder patient care.
Marcel Botha, CEO and founder of 10XBeta, a MedTech innovation firm and venture studio, joined MobiHealthNews to discuss the widespread and unintended consequences of tariffs imposed by the Trump administration on the MedTech supply chain.
Botha states that these tariffs will impact not only final medical products but also critical components and subassemblies, thereby hindering the ability of U.S.-based manufacturers to operate efficiently.
MobiHealthNews: How do you think the tariffs President Donald Trump has or will impose may affect the MedTech supply chain?
Marcel Botha: We’re already seeing a massive impact from the tariffs. We...
Today's Sponsors
Today's Sponsor